Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Werewolf Therapeutics (HOWL) Return on Sales (2022 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Return on Sales for 4 consecutive years, with 64.43% as the latest value for Q1 2025.

  • Quarterly Return on Sales fell 4261.0% to 64.43% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 64.43% through Mar 2025, down 6187.0% year-over-year, with the annual reading at 37.97% for FY2024, 3616.0% down from the prior year.
  • Return on Sales for Q1 2025 was 64.43% at Werewolf Therapeutics, down from 37.97% in the prior quarter.
  • The five-year high for Return on Sales was 0.63% in Q2 2023, with the low at 64.43% in Q1 2025.
  • Average Return on Sales over 4 years is 14.92%, with a median of 5.79% recorded in 2023.
  • The sharpest move saw Return on Sales skyrocketed 296bps in 2023, then tumbled -4261bps in 2025.
  • Over 4 years, Return on Sales stood at 1.65% in 2022, then plummeted by -385bps to 7.99% in 2023, then tumbled by -375bps to 37.97% in 2024, then tumbled by -70bps to 64.43% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 64.43%, 37.97%, and 18.69% for Q1 2025, Q4 2024, and Q3 2024 respectively.